32
6
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T24178 |
Isatoribine
Isatoribine free base,ANA 245,Immusine,ANA-245,Isatoribine,Isatoribine monohydrate,ANA245 |
HCV Protease; TLR | Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Isatoribine(ANA245) free base 是一种有效的 TLR7 受体激动剂,具有抗丙型肝炎病毒感染活性,可用于研究HCV感染。 | |||
T4121 |
Bicyclol
SY801,双环醇 |
HBV; Autophagy | Autophagy; Microbiology/Virology |
Bicyclol (SY801) 是一种抗肝炎 HBV 和 HCV 药物。 | |||
T27586 |
IDX184
IDX-184,IDX 184 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
IDX184 是一种有效的,具有口服活性的靶向 HCV 聚合酶抑制剂和核苷聚合酶抑制剂。IDX184 有效抑制 HCV 聚合酶 (IC50=0.31 μM,Ki=52.3 nM)。 IDX184是一种肝脏靶向核苷酸前药,具有抗HCV活性,可抑制HCV NS5B聚合酶,可与聚乙二醇化干扰素-α2a 和利巴韦林联合用于初治慢性丙型肝炎。 | |||
T27499 |
GSK-A1
|
HCV Protease; PI4K | Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
GSK-A1 是 III 型磷脂酰肌醇 4-激酶 PI4KA 选择性抑制剂,pIC50为 8.5-9.8,抑制 PtdIns(4,5)P2 再合成,IC50约为 3 nM。GSK-A1有效降低 PtdIns(4)P 的水平,而对 PtdIns(4,5)P2 没影响。GSK-A1在抗丙型肝炎病毒方面有研究的潜力。 | |||
T12962 |
Sofosbuvir impurity G
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity G 是 Sofosbuvir 的非对映异构体,是 Sofosbuvir 的杂质。其中 Sofosbuvir 能够抑制 HCVRNA 的复制,具有抗丙型肝炎病毒作用。 | |||
T10067 |
2',5-Difluoro-2'-deoxycytidine
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
2',5-Difluoro-2'-deoxycytidine has potent anti-HCV activity and toxicity to rRNA. | |||
T12960 |
Sofosbuvir impurity E
|
Others | Others |
Sofosbuvir impurity E is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T13281 |
Valopicitabine
NM283 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Valopicitabine is an effective prodrug of the effective anti-HCV drug 2'-C-methylcytidine and can be used as a promising antiviral drug for the study of chronic HCV infection. | |||
T62993 |
IMB-26
|
||
IMB-26 是一种 HCV 抑制剂 (EC50: 2.1 μM),显示出有效的抗 HCV 作用。 | |||
T14180 |
Alisporivir
DEB-025,Debio-025 |
Others | Others |
Alisporivir (Debio-025) is a cyclophilin inhibitor molecule.It has potent anti-hepatitis C virus (HCV) activity. | |||
T12957 |
Sofosbuvir impurity B
|
Others | Others |
Sofosbuvir impurity B is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay, with potent anti-hepatitis C virus (HCV) activity. | |||
T12955 |
Sofosbuvir D6
PSI-7977 D6,GS-7977 D6 |
Others | Others |
Sofosbuvir D6 is the deuterium labeled Sofosbuvir. Sofosbuvir is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity. | |||
T12966 | Sofosbuvir impurity K | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity K is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T10919 |
Cyclophilin inhibitor 1
|
Others | Others |
Cyclophilin inhibitor 1 is an effective and orally bioavailable cyclophilin A inhibitor with a Kd of 5 nM, showing potent anti-HCV activity, and an EC50 for HCV 2a of 98 nM. | |||
T12969 |
Sofosbuvir impurity N
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity N is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T12965 |
Sofosbuvir impurity J
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity J is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T12964 |
Sofosbuvir impurity I
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity I is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T12959 |
Sofosbuvir impurity D
|
Others | Others |
Sofosbuvir impurity D is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T12954 |
Sofosbuvir 13CD3
GS-7977 13CD3,PSI-7977 13CD3 |
Others | Others |
Sofosbuvir 13CD3 is the deuterium labeled Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay, with potent anti-hepatitis C virus (HCV) activity. | |||
T12958 | Sofosbuvir impurity C | Others | Others |
Sofosbuvir impurity C is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T12968 |
Sofosbuvir impurity M
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity M is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T11549 |
Helioxanthin 8-1
Helioxanthin analogue 8-1 |
Others | Others |
Helioxanthin 8-1, an analogue of helioxanthin, exhibits significant in vitro anti-HBV/HCV/HSV-1/HIV activity with EC50 of >5/10/1.4/15 μM. | |||
TNU0180 |
7-Deazaguanosine
|
||
Nucleoside Derivatives - 7-Deaza-purine nucleosides; Drugs and Inhibitors; Antiviral agent, anti-HCV | |||
T64220 |
Cyclophilin inhibitor 3
|
||
Cyclophilin inhibitor 3 (compound 7c) 是一种 cyclophilin A (CypA) 的有效抑制剂,表现出有效的抗 HCV 作用,其 EC50 值为 4.2 μM。 | |||
T74720 |
Mipomersen
|
||
Mipomersen (ISIS 301012 free base) 是载脂蛋白 B(apoB)的反义寡核苷酸抑制剂。Mipomersen 具有抗HCV 的作用,可降低HCV 的感染性。Mipomersen 可用于纯合子家族性高胆固醇血症 (HoFH) 的研究。 | |||
T63396 | HCV-IN-38 | ||
HCV-IN-38 是选择性的、有效的、口服具有活力的丙型肝炎病毒 (HCV) 抑制剂,其EC50值为15 nM,SI 值为431。HCV-IN-38 具有良好的安全性及口服药代动力学,表现出较高的抗HCV 活性和较低的细胞毒性作用。 | |||
T12967 |
Sofosbuvir impurity L
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity L is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T12963 |
Sofosbuvir impurity H
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity H, an diastereoisomer of Sofosbuvir, is the impurity of Sofosbuvir. Sofosbuvir (PSI-7977) is a diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T14493 |
Balapiravir
R1626,Ro 4588161 |
Others | Others |
Balapiravir (R1626, Ro 4588161) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479). IC50 Value: Target: HCV Balapiravir was discontinued for safety reasons in 28-36% of patients (m | |||
T61871 | DC-LC3in-D5 | ||
DC-LC3in-D5 is a chemical compound that functions as an autophagy inhibitor by diminishing the process of LC3B lipidation. It forms a binding association with LC3B, disrupting the LC3B-LBP2 interaction with an IC50 of 200 nM. This compound, DC-LC3in-D5, exhibits potential for application in anti-HCV or combination cancer treatments by effectively inhibiting autophagy [1]. | |||
T36880 |
NHC-diphosphate
|
||
NHC-diphosphate is an active phosphorylated intracellular metabolite of β-d-N4-Hydroxycytidine (NHC) as a diphosphate form[1]. NHC is a pyrimidine ribonucleoside and behaves as a potent anti-virus agent. NHC effectively inhibits the replication of venezuelan equine encephalitis virus (VEEV), Chikungunya virus (CHIKV) and hepatitis C virus (HCV)[1]. Huh-7 cells are incubated with (10-50 μM; 4 h) NHC or a McGuigan phosphoramidate prodrug of NHC.Intracellular levels of the parental compounds and ... | |||
T36882 |
CAY10773
|
||
CAY10773 is a derivative of the ferroptosis inducer sorafenib .1It selectively inhibits proliferation of BEL-7402, MGC803, and T24 bladder cancer cells (IC50s = 5.77, 5.21 and 3.97 μM, respectively) over non-cancerous HCV-29 cells (IC50= 23.19 μM). CAY10773 induces apoptosis in T24 cells when used at concentrations ranging from 2 to 6 μM but induces ferroptosis at concentrations greater than or equal to 6 μM with 10 hour or longer incubation times. It increases the production of reactive oxygen ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN6732 |
Oenothein B
|
Apoptosis; HCV Protease; Antibacterial; Antifungal | Apoptosis; Microbiology/Virology; Proteases/Proteasome |
Oenothein B 是一种聚(ADP-核糖)糖水解酶的特异性抑制剂。 Oenothein B 具有抗氧化、抗炎、抗真菌、抗 HCV 和抗肿瘤特性。 | |||
T7203 |
Oglufanide
奥谷法奈,L-Glutamyl-L-tryptophan,H-Glu-Trp-OH |
VEGFR; HCV Protease; Endogenous Metabolite | Angiogenesis; Metabolism; Microbiology/Virology; Proteases/Proteasome; Tyrosine Kinase/Adaptors |
Oglufanide (H-Glu-Trp-OH) 是一种从小牛胸腺中分离出来的二肽免疫调节剂,可抑制血管内皮生长因子,可刺激细胞内细菌感染和对丙型肝炎病毒的免疫反应。 | |||
TN2089 |
Platycodin D3
桔梗皂苷D3,桔梗皂苷 D3 |
HCV Protease; NF-κB | Microbiology/Virology; NF-κB; Proteases/Proteasome |
Platycodin D3 是桔梗中有抗HCV 活性的一种三萜皂苷类天然产物。 | |||
TN6508 |
Trachelogenin
(-)-Trachelogenin |
Virus Protease; c-Myc; HCV Protease; Wnt/beta-catenin | Cell Cycle/Checkpoint; Cytoskeletal Signaling; Microbiology/Virology; Proteases/Proteasome; Stem Cells |
Trachelogenin ((-)-Trachelogenin) 分离自Combretum fruticosum,是一种 HCV 进入抑制剂 具有抗增殖作用,其机制与影响β-Catenin 信号通路中的 β-Catenin、c-Myc 和 GSK3 等关键蛋白的磷酸化有关,且呈浓度依赖性。Trachelogenin具有抗病毒、抗炎和镇痛活性,在 HCVcc 和 HCVpp 模型中的 IC50 分别为 0.325 和 0.259 μg/mL。 | |||
TN1138 |
γ-Fagarine
γ-崖椒碱,gamma-Fagarine |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
gamma-Fagarine possesses moderate levels of anti-HCV activities with IC50 values being 20.4 ± 0.4 ug/ml, respectively. It has sister chromatid exchanges (SCEs)-inducing activity | |||
TN3438 | Arborinine | HCV Protease; Antifection | Microbiology/Virology; Proteases/Proteasome |
Arborinine shows mild in vitro antibacterial activity, it possesses moderate levels of anti-hepatitis C virus(HCV) activities with the IC50 values being 6.4 ± 0.7 ug/ml. Arborinine shows antifeedant activity against Spodoptera frugiperda. Arborinin shows |